Literature DB >> 30293971

Open-Label Placebo: Reflections on a Research Agenda.

Ted J Kaptchuk.   

Abstract

Open-label placebos (OLP)-placebo pills honestly prescribed-have challenged the notion that placebos require either deception or concealment to evoke salubrious benefits. This essay describes how the author arrived at the counter-intuitive OLP hypothesis, discusses evidence for OLP effectiveness, and examines mechanistic explanations for OLP. Current dominant theories such as expectation and conditioning are found to be insufficient or inaccurate. The author proposes that emerging concepts of prediction and error processing (PEP), Bayesian brain, and embodied cognition are more appropriate models for understanding OLP. As a neural processing model, PEP argues that sensory predictions are embedded in and inseparable from perceptions; PEP circumvents mind-body dualism. The author discusses how OLP, mostly non-consciously, might perturb aberrant symptom amplifications and central sensitization resulting in perceptions of improvement in symptoms. Placebo effects are neurologically encoded predictions, less what patients think and more what they enact and perform.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30293971     DOI: 10.1353/pbm.2018.0045

Source DB:  PubMed          Journal:  Perspect Biol Med        ISSN: 0031-5982            Impact factor:   1.416


  37 in total

1.  Primary care providers' use of and attitudes towards placebos: An exploratory focus group study with US physicians.

Authors:  Michael H Bernstein; Cosima Locher; Sif Stewart-Ferrer; Sarah Buergler; Catherine M DesRoches; Michelle L Dossett; Franklin G Miller; Deborah Grose; Charlotte R Blease
Journal:  Br J Health Psychol       Date:  2020-05-30

2.  Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits?

Authors:  Ted J Kaptchuk; Franklin G Miller
Journal:  BMJ       Date:  2018-10-02

3.  Are Conditioned Open Placebos Feasible as an Adjunctive Treatment to Opioids? Results from a Single-Group Dose-Extender Pilot Study with Acute Pain Patients.

Authors:  Michael H Bernstein; Molly Magill; Arnold-Peter Weiss; Ted J Kaptchuk; Charlotte Blease; Irving Kirsch; Josiah D Rich; Sara J Becker; Steven Mach; Francesca L Beaudoin
Journal:  Psychother Psychosom       Date:  2019-09-27       Impact factor: 17.659

Review 4.  Design and conduct of confirmatory chronic pain clinical trials.

Authors:  Nathaniel Katz
Journal:  Pain Rep       Date:  2020-12-18

5.  Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery.

Authors:  Valerie Hruschak; K Mikayla Flowers; Megan Patton; Victoria Merchantz; Emily Schwartz; Robert Edwards; Ted Kaptchuk; James Kang; Michelle Dossett; Kristin Schreiber
Journal:  Int J Behav Med       Date:  2022-08-01

Review 6.  Functional neurological disorder and placebo and nocebo effects: shared mechanisms.

Authors:  Mark J Edwards; Michele Tinazzi; Mirta Fiorio; Miriam Braga; Angela Marotta; Bernardo Villa-Sánchez; Diletta Barbiani
Journal:  Nat Rev Neurol       Date:  2022-09-08       Impact factor: 44.711

7.  Treating Pain With Open-Label Placebos: A Qualitative Study With Post-Surgical Pain Patients.

Authors:  Michael H Bernstein; Nathaniel Fuchs; Maayan Rosenfield; Arnold-Peter Weiss; Charlotte Blease; Cosima Locher; Molly Magill; Josiah Rich; Francesca L Beaudoin
Journal:  J Pain       Date:  2021-05-15       Impact factor: 5.820

8.  Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations.

Authors:  Nathaniel Katz; Robert H Dworkin; Richard North; Simon Thomson; Sam Eldabe; Salim M Hayek; Brian H Kopell; John Markman; Ali Rezai; Rod S Taylor; Dennis C Turk; Eric Buchser; Howard Fields; Gregory Fiore; McKenzie Ferguson; Jennifer Gewandter; Chris Hilker; Roshini Jain; Angela Leitner; John Loeser; Ewan McNicol; Turo Nurmikko; Jane Shipley; Rahul Singh; Andrea Trescot; Robert van Dongen; Lalit Venkatesan
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961

9.  Placebo From an Enactive Perspective.

Authors:  Iñigo R Arandia; Ezequiel A Di Paolo
Journal:  Front Psychol       Date:  2021-06-02

10.  Open-label placebo treatment to improve relaxation training effects in healthy psychology students: a randomized controlled trial.

Authors:  Anne Schienle; Isabella Unger
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.